GRCL — Gracell Biotechnologies Share News
0.000.00%
Last trade - 00:00- $972.69m
- $750.11m
Gracell Biotechnologies Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Orbimed Advisors Reports 11.2% Stake In Gracell Biotechnologies
Gracell Biotechnologies Inc reports results for the quarter ended in December - Earnings Summary
Brief: Gracell Biotechnologies Reports Fourth Quarter And Full Year 2022 Unaudited Financial Results, And Provides Corporate Update
Gracell Biotechnologies Inc expected to post a loss of 13 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Ralph Lauren, Howmet, Insulet
U.S. STOCKS ON THE MOVE-Top Ships, Brightcove, Airbnb
U.S. STOCKS ON THE MOVE-Ocular Therapeutix, Microsoft, Novavax
Gracell Bio rises as China greenlights bone marrow cancer therapy trial
Brief: Gracell Biotechnologies Announces China NMPA Clearance For IND Application For Phase 1/2 Clinical Trial Of Fastcar-T GC012F
U.S. STOCKS ON THE MOVE-Energy index, Church & Dwight, Personalis
U.S. STOCKS ON THE MOVE-Gracell Bio, Zimmer Biomet, Clorox
Gracell Bio jumps on FDA nod to begin human trials for blood cancer therapy
Brief: Gracell Biotechnologies Announces FDA Clearance Of Ind Application For Phase 1B/2 Clinical Trial Of Fastcar-T Gc012f
Refile: BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Starbucks, ASLAN Pharma
U.S. STOCKS ON THE MOVE-Jasper Therapeutics, Blackstone, Mondelez
U.S. STOCKS ON THE MOVE-Horizon Global, Apple, PayPal Holdings
Jefferies sees opportunity in biotech stocks trading below cash level
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber